Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body × IFL protocol × Gastrointestinal × Clear all

NCT02563002 2024-10-03

KEYNOTE-177

Phase 3 Completed

307 enrolled 16 charts 2 FDA

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms